Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.

The Journal of clinical endocrinology and metabolism - 1 May 2013

Zhang Zeng, He Jin-Wei, Fu Wen-Zhen, Zhang Chang-Qing, Zhang Zhen-Lin

Abstract excerpt

CONTEXT: We previously demonstrated that deficiency of the prostaglandin transporter (SLCO2A1) is a cause of primary hypertrophic osteoarthropathy (PHO). However, its clinical and metabolic characteristics have not been well defined. OBJECTIVE: The objective of the study was to expand this mutational spectrum to better delineate the SLCO2A1 deficiency phenotype and investigate the clinical and metabolic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dinoprostone

Share to Family Health

Share to Organic Anion Transporters

Share to Prostaglandins

Share to Protein Structure, Secondary

Share to Sequence Alignment

Source

Identifiers

PMID: 23509104
DOI: 10.1210/jc.2012-3568

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutations in the SLCO2A1 gene and primary hypertrophic osteoarthropathy: a clinical and biochemical characterization.PMID 23509104Read ↗

Identification of mutations in the prostaglandin transporter gene SLCO2A1 and phenotypic comparison between two subtypes of primary hypertrophic osteoarthropathy (PHO): A single-center study.Semantic proximity Read ↗

Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy.Semantic proximity Read ↗

Novel SLCO2A1 mutations cause gender-differentiated pachydermoperiostosisSemantic proximity Read ↗

Primary hypertrophic osteoarthropathy with severe arthralgia identified by gene mutation of SLCO2A1.Semantic proximity Read ↗

A novel variant in the SLCO2A1 gene in a Chinese patient with chronic gastroenteropathy and primary hypertrophic osteoarthropathy.Semantic proximity Read ↗

Chronic Enteropathy Associated with SLCO2A1-Associated Primary Hypertrophic Osteoarthropathy in Female Patients: A Case Report and Literature ReviewSemantic proximity Read ↗

A novel mutation in the SLCO2A1 gene, encoding a prostaglandin transporter, induces chronic enteropathy.Semantic proximity Read ↗

Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis.Semantic proximity Read ↗

Clinical and biochemical characteristics of 12 Chinese primary hypertrophic osteoarthropathy patients with HPGD mutations.Semantic proximity Read ↗

Identification of two novel mutations in the SLCO2A1 prostaglandin transporter gene in a Chinese patient with primary hypertrophic osteoarthropathy.Semantic proximity Read ↗

Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy.Semantic proximity Read ↗

Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.